Comparative Effectiveness of Guidelines for Managing Hyperlipidemia and Hypertension in Type 2 Diabetes Patients
Author Information
Author(s): Shah Nilay D., Mason Jennifer, Kurt Murat, Denton Brian T., Schaefer Andrew J., Montori Victor M., Smith Steven A.
Primary Institution: Mayo Clinic
Hypothesis
The efficiency and effectiveness of international guidelines for managing hypertension and hyperlipidemia in type 2 diabetes patients are unclear.
Conclusion
International guidelines are similar in effectiveness but differ significantly in expected medication costs.
Supporting Evidence
- All guidelines are equally effective in preventing cardiovascular events.
- Medication costs vary significantly across different guidelines.
- The Australian guidelines have the highest expected medication costs.
- The US guidelines are generally more efficient compared to other published guidelines.
- Incremental changes in guidelines did not significantly impact absolute risk for primary prevention.
Takeaway
Different countries have guidelines for treating diabetes, but they all work about the same; however, some are much more expensive than others.
Methodology
A Markov model was used to compare the efficiency and effectiveness of guidelines for managing hypertension and hyperlipidemia in type 2 diabetes patients aged 40-80.
Potential Biases
Potential conflicts of interest in guideline formulation may influence recommendations.
Limitations
The model is based on point estimates and does not consider medication adverse effects, non-adherence, or discontinuation.
Participant Demographics
Caucasian, non-smoking patients aged 40-80 with type 2 diabetes.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website